Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial

Kaouthar Beltaief; Mohamed Amine Msolli; Asma Zorgati; Adel Sekma; Marwen Fakhfakh; Maryem Ben Marzouk; Hamdi Boubaker; Mohamed Habib Grissa; Mehdi Methamem; Riadh Boukef; Asma Belguith; Wahid Bouida; Semir Nouira

doi:10.1111/acem.13560

Nebulized Terbutaline and Ipratropium Bromide Versus Terbutaline Alone in Acute Exacerbation of Chronic Obstructive Pulmonary Disease Requiring Noninvasive Ventilation: A Randomized Double‐blind Controlled Trial

Academic Emergency Medicine ◽

10.1111/acem.13560 ◽

2018 ◽

Vol 26 (4) ◽

pp. 434-442

Author(s):

Kaouthar Beltaief ◽

Mohamed Amine Msolli ◽

Asma Zorgati ◽

Adel Sekma ◽

Marwen Fakhfakh ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Noninvasive Ventilation ◽

Ipratropium Bromide ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease

A multicenter randomized, double-blind, placebo-controlled trial to evaluate the safety and efficacy of rhubarb in treating acute exacerbation of chronic obstructive pulmonary disease of the syndrome type phlegm-heat obstructing the lungs

Journal of Traditional Chinese Medical Sciences ◽

10.1016/j.jtcms.2016.07.002 ◽

2016 ◽

Vol 3 (2) ◽

pp. 71-80

Author(s):

Fengjie Zheng ◽

Yan Sun ◽

Xianggen Zhong ◽

Yueqi Wang ◽

Ruohan Wu ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Syndrome Type ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Safety And Efficacy ◽

Double Blind Placebo

Faculty Opinions recommendation of Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718313352.793493922 ◽

2014 ◽

Author(s):

Mark Dransfield ◽

Michael Wells ◽

Surya Bhatt

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

Faculty Opinions recommendation of Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718348198.793494105 ◽

2014 ◽

Author(s):

Adam Wanner ◽

Timothy Scialla

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Parallel Group

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor

Twice daily N-acetylcysteine 600 mg for exacerbations of chronic obstructive pulmonary disease (PANTHEON): a randomised, double-blind placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70286-8 ◽

2014 ◽

Vol 2 (3) ◽

pp. 187-194 ◽

Cited By ~ 110

Author(s):

Jin-Ping Zheng ◽

Fu-Qiang Wen ◽

Chun-Xue Bai ◽

Huan-Ying Wan ◽

Jian Kang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo

ICU Utilization for Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease Receiving Noninvasive Ventilation

Critical Care Medicine ◽

10.1097/ccm.0000000000003660 ◽

2019 ◽

Vol 47 (5) ◽

pp. 677-684 ◽

Cited By ~ 4

Author(s):

Laura C. Myers ◽

Mohammad Kamal Faridi ◽

Paul Currier ◽

Carlos A. Camargo

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Noninvasive Ventilation ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Correction: Effects of Two Chinese Herbal Formulae for the Treatment of Moderate to Severe Stable Chronic Obstructive Pulmonary Disease: A Multicenter, Double-Blind, Randomized Controlled Trial

PLoS ONE ◽

10.1371/journal.pone.0152379 ◽

2016 ◽

Vol 11 (3) ◽

pp. e0152379

Author(s):

Genfa Wang ◽

Baojun Liu ◽

Yuxue Cao ◽

Yijie Du ◽

Hongying Zhang ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Randomized Controlled Trial ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Randomized Controlled ◽

Chinese Herbal ◽

Herbal Formulae

Success rate during noninvasive ventilation in acute exacerbation of chronic obstructive pulmonary disease: a real-life study? Authors' reply

Polish Archives of Internal Medicine ◽

10.20452/pamw.2666 ◽

2015 ◽

Vol 125 (1-2) ◽

pp. 104-104

Author(s):

Antonello Nicolini ◽

Lorenzo Ferrera ◽

Mario Santo ◽

Maura Ferrari-Bravo ◽

Manuela Del Forno ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Success Rate ◽

Pulmonary Disease ◽

Acute Exacerbation ◽

Noninvasive Ventilation ◽

Real Life ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease ◽

Life Study ◽

Real Life Study

A controlled trial of noninvasive ventilation for chronic obstructive pulmonary disease exacerbations

Journal of Critical Care ◽

10.1016/j.jcrc.2008.08.007 ◽

2009 ◽

Vol 24 (3) ◽

pp. 473.e7-473.e14 ◽

Cited By ~ 26

Author(s):

Miguel Carrera ◽

José M. Marín ◽

Antonio Antón ◽

Eusebi Chiner ◽

Maria L. Alonso ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Noninvasive Ventilation ◽

Controlled Trial ◽

Chronic Obstructive ◽

Obstructive Pulmonary Disease

Doxycycline for outpatient-treated acute exacerbations of Chronic obstructive pulmonary disease (COPD): a randomized double-blind placebo-controlled trial

Journal of Emergency Medicine ◽

10.1016/j.jemermed.2017.08.080 ◽

2017 ◽

Vol 53 (4) ◽

pp. 597

Author(s):

Krysia Crabtree

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Double Blind Placebo ◽

Acute Exacerbations